Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area, By Type of software solution, By Mode of Deployment, By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization) , By Scale of Operation, By Region, And By Segment Forecasts, 2025-2034
Market Segmentation:
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Application Area
· Donor & Patient Enrollment
· Sample Collection & Processing
· Manufacturing & Quality Operations
· Cryogenic Logistics & Distribution
· Patient Administration & Follow-Up
· Data Integration & Regulatory Compliance
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Type of Software Solution
· Cell Orchestration Platforms (COI/COC)
· Manufacturing Execution Systems (MES)
· Inventory & Material Management Systems
· Laboratory Information Management Systems (LIMS)
· Logistics & Supply Chain Management Platforms
· Patient & Donor Management Systems
· Quality & Compliance Management Systems (QMS)
· Tracking, Traceability & Analytics Platforms
· Integrated Data / Interoperability Layers
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on End-User
· Biobanks & Repository Operators
· Cell Therapy Manufacturing Facilities
· Hospitals & Transplant Centers
· Research Institutes / Academic Medical Centers
· Biopharma & CGT Developers
· CDMOs / CROs
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Scale of Operation
- Clinical Scale
- Commercial Scale
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Type of Deployment
· Cloud-Based
· On-Premises
· Hybrid
· SaaS Subscription
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2025 to 2034 based on Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
- U.S.
- Canada
Europe Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics market revenue (US$ Million) by Country, 2025 to 2034
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Landscape
- Company Overview
- Financial Performance
- Key Development
- Latest Strategic Developments
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell and Gene Therapy Supply Chain/Logistics Market Snapshot
Chapter 4. Global Cell and Gene Therapy Supply Chain/Logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Application Area Estimates & Trend Analysis
5.1. By Applications & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Application Area:
5.2.1. Donor eligibility assessment
5.2.2. Sample collection
5.2.3. Manufacturing
5.2.4. Logistics
5.2.5. Patient verification and treatment follow-up
Chapter 6. Market Segmentation 1: By Type of Software Solution Estimates & Trend Analysis
6.1. By Software Solution & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Type of Software Solution:
6.2.1. Cell orchestration platform
6.2.2. Enterprise manufacturing system
6.2.3. Inventory management system
6.2.4. Laboratory information management system
6.2.5. Logistics management system
6.2.6. Patient management system
6.2.7. Quality management system
6.2.8. Tracking and tracing system
Chapter 7. Market Segmentation 1: By End-User Estimates & Trend Analysis
7.1. By End User & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By End-User:
7.2.1. Biobank
7.2.2. Cell Therapy Lab
7.2.3. Hospital
7.2.4. Research Institute
7.2.5. Commercial Organization
Chapter 8. Market Segmentation 2: By Mode of Deployment Estimates & Trend Analysis
8.1. By Mode of Deployment & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2024 to 2034 for the following By Mode of Deployment:
8.2.1. Cloud
8.2.2. On-premises
Chapter 9. Cell and Gene Therapy Supply Chain/Logistics Market Segmentation 3: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.1.2. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.1.3. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.1.4. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.1.5. North America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.2.2. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.2.3. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2021-2034
9.2.4. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.2.5. Europe Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.3.2. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.3.3. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, 2021-2034
9.3.4. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.3.5. Asia Pacific Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.4.2. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.4.3. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million)
9.4.4. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.4.5. Latin America Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Application Area, 2021-2034
9.5.2. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts By Type of Software Solution, 2021-2034
9.5.3. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) By End-User, (US$ Million)
9.5.4. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) estimates and forecasts by Mode of Deployment, 2021-2034
9.5.5. Middle East & Africa Cell and Gene Therapy Supply Chain/Logistics Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Be The Match BioTherapies
10.2.2. MAK-SYSTEM
10.2.3. Cryoport
10.2.4. Brooks Life Sciences
10.2.5. Lykan Bioscience
10.2.6. Clarkston Consulting
10.2.7. SAP
10.2.8. Hypertrust Patient Data Care
10.2.9. Haemonetics
10.2.10. MasterControl
10.2.11. TraceLink
10.2.12. SAVSU Technologies
10.2.13. TrakCel
10.2.14. Title21 Health Solutions
10.2.15. sedApta Group
10.2.16. Vineti
10.2.17. Stafa Cellular Therapy
10.2.18. Thermo Fisher Scientific(Patheon)
10.2.19. McKesson
10.2.20. Biocair
10.2.21. Marken(UPS Company)
10.2.22. Modality Solutions
10.2.23. Almac
10.2.24. Arvato Supply Chain Solutions SE
10.2.25. Catalent, Inc
10.2.26. BioLife Solutions, Inc
10.2.27. Biostor Ltd
10.2.28. Yourway Biopharma Services Company
10.2.29. Atelerix Ltd
10.2.30. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.5 Billion in 2024 and is predicted to reach 4.4 Billion by the year 2034
Cell and Gene Therapy Supply Chain/Logistics Market is expected to grow at an 11.9 % CAGR during the forecast period for 2025-2034
Be The Match BioTherapies, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Lykan Bioscience, Clarkston Consulting, SAP, Hypertrust Patient Data Care
Application area, Type of software solution, Mode of Deployment, End-user, Scale of operation are the key segments of the Cell and Gene Therapy Supply Chain/Logistics
North American region is leading the Cell and Gene Therapy Supply Chain/Logistics Market.